AbbVie Inc. (BMV:ABBV)

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of MXN 6.66 trillion. The enterprise value is 7.77 trillion.

Market Cap	6.66T
Enterprise Value	7.77T

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Jan 16, 2026

Share Statistics

Current Share Class	1.77B
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	73.71%
Float	1.76B

Valuation Ratios

The trailing PE ratio is 154.53 and the forward PE ratio is 15.74.

PE Ratio	154.53
Forward PE	15.74
PS Ratio	6.08
PB Ratio	-139.61
P/TBV Ratio	n/a
P/FCF Ratio	18.43
P/OCF Ratio	17.39
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.78, with an EV/FCF ratio of 21.51.

EV / Earnings	180.36
EV / Sales	7.40
EV / EBITDA	14.78
EV / EBIT	20.76
EV / FCF	21.51

Financial Position

The company has a current ratio of 0.72

Current Ratio	0.72
Quick Ratio	0.47
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.50
Interest Coverage	7.38

Financial Efficiency

Return on equity (ROE) is 137.96% and return on invested capital (ROIC) is 18.51%.

Return on Equity (ROE)	137.96%
Return on Assets (ROA)	9.59%
Return on Invested Capital (ROIC)	18.51%
Return on Capital Employed (ROCE)	22.50%
Revenue Per Employee	19.89M
Profits Per Employee	783,045
Employee Count	55,000
Asset Turnover	0.43
Inventory Turnover	3.63

Taxes

Income Tax	-13.48B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.28% in the last 52 weeks. The beta is 0.35, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	+8.28%
50-Day Moving Average	4,150.50
200-Day Moving Average	3,849.83
Relative Strength Index (RSI)	35.71
Average Volume (20 Days)	733

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.32

Income Statement

In the last 12 months, AbbVie had revenue of MXN 1.09 trillion and earned 43.07 billion in profits. Earnings per share was 24.22.

Revenue	1.09T
Gross Profit	781.78B
Operating Income	390.05B
Pretax Income	30.45B
Net Income	43.07B
EBITDA	541.44B
EBIT	390.05B
Earnings Per Share (EPS)	24.22

Balance Sheet

The company has 104.02 billion in cash and 1.26 trillion in debt, with a net cash position of -1,158.82 billion.

Cash & Cash Equivalents	104.02B
Total Debt	1.26T
Net Cash	-1,158.82B
Net Cash Per Share	n/a
Equity (Book Value)	-47.67B
Book Value Per Share	-27.42
Working Capital	-199.05B

Cash Flow

In the last 12 months, operating cash flow was 382.62 billion and capital expenditures -21.57 billion, giving a free cash flow of 361.05 billion.

Operating Cash Flow	382.62B
Capital Expenditures	-21.57B
Free Cash Flow	361.05B
FCF Per Share	n/a

Margins

Gross margin is 71.46%, with operating and profit margins of 35.65% and 4.00%.

Gross Margin	71.46%
Operating Margin	35.65%
Pretax Margin	2.78%
Profit Margin	4.00%
EBITDA Margin	49.49%
EBIT Margin	35.65%
FCF Margin	33.00%

Dividends & Yields

This stock pays an annual dividend of 124.74, which amounts to a dividend yield of 3.29%.

Dividend Per Share	124.74
Dividend Yield	3.29%
Dividend Growth (YoY)	7.00%
Years of Dividend Growth	2
Payout Ratio	481.49%
Buyback Yield	-0.01%
Shareholder Yield	3.28%
Earnings Yield	0.65%
FCF Yield	5.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.21 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.21
Piotroski F-Score	7